Delivery Order SPE2DB24D1205-SPE2DB25FDARV
- Not listed
- The Defense Logistics Agency awarded a $17,220.86 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg on September 15, 2025, with an ultimate completion date of October 6, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for $8,630.28 under firm fixed pricing. The order covers 60 capsules of Ofev 100 mg, a pharmaceutical product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with completion scheduled for July 16, 2025. This is a non-set-aside, competitively awarded delivery order with no small business or disadvantaged veteran designations applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ofev 100 mg capsules (60-count) with a ceiling value of $8,630.28. This firm fixed-price delivery order is set to be completed by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, demonstrating AmerisourceBergen's continued capability to meet federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $8,630.28. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a contract ceiling value of $34,362.32. This firm fixed-price delivery order, with an ultimate completion date of October 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $8,630.28 delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev 100 mg capsules (60-count units) on July 15, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units). This firm fixed-price, non-set-aside contract was competitively awarded on August 14, 2025, with an ultimate completion date of September 5, 2025. The pharmaceutical products will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,260.58 to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 100 mg capsules on September 17, 2025, with an ultimate completion date of October 8, 2025. This non-set-aside, firm fixed-price contract represents a competitive award to the pharmaceutical distributor and represents medical supply procurement for federal healthcare needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDARVDelivery Order
The Defense Logistics Agency (DLA) awarded a $17,260.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product. The award was made on September 19, 2025, with an ultimate completion date of October 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications, medical supplies, vaccines, and related healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its established capability as a critical vendor for federal medical procurement, consistently delivering pharmaceutical products through competitive awards with the DLA and supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 9/19/25 |